Increase in creatinine levels associated with niraparib maintenance therapy in ovarian cancer.

Yoshifumi TakahashiMasahiro TaguchiKohei TamuraMiki ShinoharaTakahiro KoyanagiSuzuyo TakahashiAkiyo TaneichiYuji TakeiYasushi SagaHiroyuki Fujiwara

Published in: The journal of obstetrics and gynaecology research (2023)

Niraparib maintenance therapy frequently increased serum creatinine, but the change was reversible. Further studies are needed to determine the effects of niraparib on renal function in Japanese patients.

Keyphrases

uric acid
stem cells
bone marrow
cell therapy